¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"immunoglobulins, surface"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® surface tension ÇÑ±Û Ç¥¸éÀå·Â
¼³¸í   
  ¾×üÀÇ ÀÚÀ¯Ç¥¸é¿¡¼­ Ç¥¸éÀ» ÀÛ°ÔÇÏ·Á°í ÀÛ¿ëÇϴ Àå·Â. ºñ´©¹æ¿ïÀ̳ª ¾×ü ¼ÓÀÇ ±âÆ÷-¹°¹æ¿ï µîÀÌ ±¸»óÀÌ µÇ´Â °ÍÀº ÀÌ ÈûÀÌ ¾×¸é¿¡ ÀÛ¿ëÇϱ⠶§¹®À̸ç, ¿ë±âÀÇ °¡ÀåÀÚ¸®¿¡ ¾×ü°¡ ³ÑÃÄ ¿Ã¶ó°£ ¸ð¾çÀÌ µÇ¾î ½ñ¾ÆÁöÁö ¾Ê´Â °Íµµ ¾×ü Ç¥¸é¿¡ Àå·ÂÀÌ ÀÛ¿ëÇϱ⠶§¹®ÀÌ´Ù. ¼ö¸é¿¡ ¶³¾î¶ß¸° ±â¸§¹æ¿ïÀÌ ±Ý¹æ ÆÛÁö´Â °ÍÀº ¹°ÀǠǥ¸éÀå·ÂÀÌ ±â¸§ÀǠǥ¸éÀå·Âº¸´Ù Å©°í, ±â¸§ÃþÀÌ ¹°ÀǠǥ¸éÀå·Â¿¡ ÀÇÇØ Àâ¾Æ ´Ã¿©Áö±â ¶§¹®ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • approximal surface
    Á¢Ã˸é, ÀÎÁ¢¸é
  • articular surface
    °üÀý¸é
  • body surface mapping
    üǥ¸éÀüÀ§Áöµµ
  • cardiac surface map
    ½ÉÀåÇ¥¸éµµ
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • dorsal surface
    µîÂʸé, µÞ¸é, ¹èÃø¸é
  • fetal surface
    žÆ(ÂÊ)¸é
  • free surface
    ÀÚÀ¯¸é
  • hepatitis B surface antigen
    BÇü°£¿°Ç¥¸éÇ׿ø
  • internal surface
    ¼Ó¸é, ³»¸é
  • lateral surface
    °¡Âʸé, ¿ÜÃø¸é, Ãø¸é
  • occlusal surface
    ±³ÇÕ¸é, ¸Â¹°¸²¸é
  • potential surface
    ÀüÀ§¸é
  • proximate surface
    ÀÎÁ¢¸é
  • quadratic surface
    ÀÌÂ÷°î¸é
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • surface antigen
    Ç¥¸éÇ׿ø
  • surface area
    üǥ¸éÀû, Ç¥¸éÀû
  • surface coil
    Ç¥¸éÄÚÀÏ, Ç¥¸é°ËÃâ±â
  • surface characteristic
    Ç¥¸éƯ¼º
  • surface electrode
    Ç¥¸éÀü±Ø
  • surface
    Ç¥¸é, ¸é
  • articular surface
    °üÀý¸é
  • dorsal surface
    µîÂʸé, µÞ¸é
  • lateral surface
    °¡Âʸé, ¿ÜÃø¸é
  • potential surface
    ÀüÀ§¸é
  • proximate surface
    ÀÎÁ¢¸é
  • surface tension
    Ç¥¸éÀå·Â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anterolateral surface
    ¾Õ°¡Âʸé
  • anteromedial surface
    ¾Õ¾ÈÂʸé
  • approximal surface
    Á¢Ã˸é
  • articular surface
    °üÀý¸é
  • hepatitis B surface antigen
    ºñÇü°£¿°Ç¥¸éÇ׿ø
  • surface anesthesia
    Ç¥¸é¸¶Ãë
  • surface antigen
    Ç¥¸éÇ׿ø
  • surface area
    üǥ¸éÀû, Ç¥¸éÀû
  • surface refrigeration anesthesia
    Ç¥¸é³Ãµ¿¸¶Ãë
  • body surface mapping
    üǥ¸éÀüÀ§µµ
  • cardiac surface map
    ½ÉÀåÇ¥¸éµµ
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • root surface cavity
    À̻Ѹ®¸é°ø°£
  • surface caries
    Ç¥¸é¿ì½Ä
  • surface catalysis
    Ç¥¸éÃ˸ÅÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Immunoglobulins
    ¸é¿ª±Û·ÎºÒ¸°
  • HBsAg => hepatitis B surface antigen
    B Çü °£¿° s Ç׿ø
  • Laibal surface
    ÀÔ¼ú¸é
  • anterior articular surface
    ¾Õ°üÀý¸é
  • anterior articular surface for talus
    ¾Õ¸ñ¸»°üÀý¸é
  • anterior calcaneal articular surface
    ¾Õ¹ß²ÞÄ¡°üÀý¸é
  • anterior surface
    ¾Õ¸é
  • anterior surface of eyelid
    ´«²¨Ç®¾Õ¸é
  • anterior surface of petrous portion
    ¹ÙÀ§¾Õ¸é
  • anterolateral surface
    ¾Õ°¡Âʸé
  • anteromedial surface
    ¾Õ¾ÈÂʸé
  • antigen, hepatitis B surface
    BÇü °£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø
  • approximal surface
    Á¢Ã˸é
  • articular surface
    °üÀý ¸é(¡­Øü).
  • articular surface
    °üÀý¸é
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anterior articular surface
    ¾Õ°üÀý¸é
  • anterior articular surface for talus
    ¾Õ¸ñ¸»°üÀý¸é
  • anterior calcaneal articular surface
    ¾Õ¹ß²ÞÄ¡°üÀý¸é
  • anterior surface
    ¾Õ¸é
  • anterior surface of eyelid
    ´«²¨Ç®¾Õ¸é
  • anterior surface of petrous portion
    ¹ÙÀ§¾Õ¸é
  • anterolateral surface
    ¾Õ°¡Âʸé
  • anteromedial surface
    ¾Õ¾ÈÂʸé
  • antigen, hepatitis B surface
    BÇü °£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø
  • approximal surface
    Á¢Ã˸é
  • articular surface
    °üÀý ¸é(¡­Øü).
  • articular surface
    °üÀý¸é
  • articular surface for cuboid bone
    ÀÔ¹æ°üÀý¸é
  • articular surface for fibula
    Á¾¾Æ¸®°üÀý¸é
  • articular surface for navicular bone
    ¹ß¹è°üÀý¸é
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Diaphragmatic surface
    °¡·Î¸·¸é
    [¿¾ ¿ë¾î] Ⱦ°Ý¸é
  • Lateral surface
    °¡Âʸé
    [¿¾ ¿ë¾î] ¿ÜÃø¸é
  • Lateral surface
    °¡Âʸé
    [¿¾ ¿ë¾î] ¿ÜÃø¿¬
  • Malleolar articular surface
    °¡Âʺ¹»ç°üÀý¸é
    [¿¾ ¿ë¾î] ¿Ü°ú°üÀý¸é
  • Lateral malleolar surface
    °¡Âʺ¹»ç¸é
    [¿¾ ¿ë¾î] ¿Ü°ú¸é
  • Costal surface
    °¥ºñ¸é
    [¿¾ ¿ë¾î] ´Á°ñ¸é
  • Articular surface of tubercle
    °¥ºñ»À°áÀý°üÀý¸é
    [¿¾ ¿ë¾î] ´Á°ñ°áÀý°üÀý¸é
  • Articular surface of head of rib
    °¥ºñ»À¸Ó¸®°üÀý¸é
    [¿¾ ¿ë¾î] ´Á°ñµÎ°üÀý¸é
  • Pelvic surface
    °ñ¹Ý¸é
    [¿¾ ¿ë¾î] Àü¸é
  • Temporal surface
    °üÀÚ¸é
    [¿¾ ¿ë¾î] ÃøµÎ¸é
  • Infratemporal surface
    °üÀھƷ¡¸é
    [¿¾ ¿ë¾î] ÃøµÎÇϸé
  • Articular surface
    °üÀý¸é
    [¿¾ ¿ë¾î] °üÀý¸é
  • Posterior surface
    °üÀý¸é
    [¿¾ ¿ë¾î] °üÀý¸é
  • Occlusal surface
    ±³ÇÕ¸é
    [¿¾ ¿ë¾î] ±³ÇÕ¸é
  • Auricular surface
    ±Í¸ð¾ç¸é
    [¿¾ ¿ë¾î] ÀÌ»ó¸é
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • variable surface glycoprotein (VSG)
    º¯À̼ºÇ¥¸é´ç´Ü¹éÁú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • contact surface
    Á¢Ã˸é(ïÈõºØü)
  • hepatitis B surface antigen
    BÇü(úþ) °£¿°(ÊÜæú) Ç¥¸é Ç׿ø(øúØüù÷ê«)
  • mixed surface film
    È¥ÇÕÇ¥¸é(ûèùêøúØü)Çʸ§
  • molecular surface
    ºÐÀÚÇ¥¸é(ÝÂí­øúØü)
  • reentrant surface
    ¿ä°¢ Ç¥¸é(èêÊÇøúØü)
  • surface-active agent
    Ç¥¸éȰ¼ºÁ¦ (øúØüüÀàõð¥)
  • surface activity
    Ç¥¸éȰ¼º (øúØüüÀàõ)
  • surface antigen
    Ç¥¸éÇ׿ø (øúØüù÷ê«)
  • surface balance
    Ç¥¸é(øúØü) Àú¿ï
  • surface factor
    Ç¥¸éÀÎÀÚ (øúØüì×í­)
  • surface membrane proteins
    Ç¥¸é¸·´Ü¹éÁú (øúØüدӱÛÜòõ)
  • surface potential
    Ç¥¸éÀüÀ§ (øúØüï³êÈ)
  • surface pressure
    Ç¥¸é¾Ð (øúØüäâ)
  • surface tension
    Ç¥¸éÀå·Â (øúØüíåÕô)
  • van der Waals surface
    ¹Ý µ§ ¹ß½º Ç¥¸é (øúØü)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • depth resolved surface coil spectroscopy [=DRESS]
    ±íÀÌÇØ°áÇ¥¸éÄÚÀϺб¤¹ý
  • free surface
    ÀÚÀ¯¸é
  • malleolar articular surface
    ³»°ú°üÀý¸é, ³»Ãøº¹»ç°üÀý¸é
  • medial surface
    ³»Ãø¸é
  • outer surface
    ¿ÜÃøÇ¥¸é
  • quadrature surface coil
    ±¸ÀûÇ¥¸éÄÚÀÏ
  • shade surface display
    ±×¸²ÀÚÇ¥¸éÇ¥½Ã
  • smooth surface
    ÆòȰ¸é
  • SSD [=shade surface display]
    ±×¸²ÀÚÇ¥¸éÇ¥½Ã
  • surface
    Ç¥¸é
  • surface coil
    Ç¥¸éÄÚÀÏ, Ç¥¸é°ËÃâ±â
  • surface rendering mode
    Ç¥¸é¿¬Ãâ¹æ½Ä
  • symphysial surface
    Ä¡°ñ°áÇÕ¸é
  • tuning of surface coil
    Ç¥¸é ÄÚÀÏÁ¶À², Ç¥¸é°ËÃâ±âÁ¶Á¤
  • ventromedial surface
    ³»ÃøÀü¸é, º¹³»Ãø
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ESA Electrolysis Society of America; endocardial surface area; epidermal surface antigen; esterase; este...
SA salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame...
SSD shaded surface display; single saturating dose; Social Security disability; source-skin distance; so...
FAB fast atom bombardment; formalin ammonium bromide; fragment, antigen-binding [of immunoglobulins]; Fr...
Fab fragment, antigen-binding [of immunoglobulins]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SmIg Surface membrane immunoglobulins
SIgA Secretory immunoglobulins A
TSI Thyroid Stimulating Immunoglobulins
TBII Thyrotrophin binding inhibiting immunoglobulins
BSA A/body surface area
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • area of body surface
    üǥ¸éÀû
  • articular surface irregularity
    °üÀý ¸éÀÇ ºÒ±ÔÄ¢¼º
  • articular surface of head of rib
    °¥ºñ»À ¸Ó¸® °üÀý¸é
  • axial surface cavity
    Ãà¸é ¿Íµ¿
    Àü¹ÝÀûÀÎ Æò¸éÀÌ Ä¡¾ÆÀÇ ÀåÃà¿¡ ÆòÇàÇÏ°Ô Çü¼ºµÈ ¿Íµ¿.
  • basal surface
    ±âÀú¸é
    denture base¸¦ º¸½Ã¿À
  • body surface area
    üǥ¸éÀû
  • body surface potential mapping
    üǥ¸é ÀüÀ§µµ
  • bony surface of the joint
    °üÀý °ñ¸é
  • boundary surface
    °è¸é
    µ¿ÀǾî=interface.
  • cardiac surface map
    ½ÉÀå Ç¥¸éµµ
  • cell surface marker
    ¼¼Æ÷ Ç¥¸é Ç¥ÁöÀÚ
  • contact surface
    Á¢Ã˸é
    °£È¤ »óÇÏ Ä¡¾Æ°£ ±³ÇÕ¸é Á¢ÃËÀ» °¡¸®Å°´Â °æ¿ìµµ ÀÖ´Ù.
  • costal surface
    ´Á°ñ ¸é
  • disc-articular surface adherence
    °üÀý¿øÆÇ-°üÀý ¸é À¯Âø
  • dorsal surface of finger
    ¼Õ°¡¶ô µî
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
immunoglobulins, surface Immunoglobulins bound to the surface of lymphocytes.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
immunoglobulins Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IgA, IgD, IgE, IgG, IgM) on the basis of structure and biological activity.
(12 Dec 1998)
immunoglobulins, alpha-chain Heavy chains found in the fab and fc fragments of IgA and having a molecular weight of approximately 58 kD. They contain about 470 amino acid residues arranged in four domains and an oligosaccharide component bound covalently to the fc fragment.
(12 Dec 1998)
immunoglobulins, delta-chain Heavy chains found in the fab and fc fragments of IgD and having a molecular weight of approximately 64 kD. They contain about 500 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the fc fragment.
(12 Dec 1998)
immunoglobulins, epsilon-chain Heavy chains found in the fab and fc fragments of IgE and having a molecular weight of approximately 72 kD. They contain about 550 amino acid residues arranged in five domains and about three times more carbohydrate than the heavy chains of IgA, IgD, and IgG.
(12 Dec 1998)
immunoglobulins, fab Antigen-binding fragments composed of one entire light chain and about half of one of the heavy chains, linked to each other by disulfide bonds. Fab contains the antigen binding site which is part of the variable region of the immunoglobulin molecule.
(12 Dec 1998)
immunoglobulins, fc Crystallizable fragments composed of the carboxy-terminal halves of both heavy chains linked to each other by disulfide bonds. Fc fragments are responsible for the effector functions of antibodies (complement fixation, binding to cell membranes, and placental transport).
(12 Dec 1998)
immunoglobulins, gamma-chain Heavy chains found in the fab and fc fragments of IgG and having a molecular weight of approximately 51 kD. They contain about 450 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the fc fragment. The gamma chains of the four IgG subgroups are not identical, but resemble each other more closely than the heavy chains of a different immunoglobulin.
(12 Dec 1998)
immunoglobulins, heavy-chain Major components of immunoglobulin molecules. They are the larger of the two types of polypeptide chains responsible for the biological and immunological properties of the different immunoglobulins. They differ according to the class of ig from which they were isolated, contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kD. One ig molecule comprises two heavy and two light chains.
(12 Dec 1998)
immunoglobulins, intravenous Immunoglobulin preparations used in intravenous infusion, containing primarily IgG. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including paediatric aids, primary hypergammaglobulinaemia, scid, cytomegalovirus infections in transplant recipients, chronic lymphocytic leukaemia, kawasaki syndrome, infection in neonates, and idiopathic thrombocytopenic purpura.
(12 Dec 1998)
immunoglobulins, j-chain The immunoglobulin fragments found in the light chain fractions of secretory IgA and polymeric IgM in a ratio of one j chain per one IgA dimer or one IgM pentamer. It is a polypeptide with a molecular weight of about 17 kD and probably serves either to bind the components of the globulins together or to transfer the globulins across membranes.
(12 Dec 1998)
immunoglobulins, kappa-chain One of the light chains of the immunoglobulins with a molecular weight of approximately 22 kD. They constitute about 60% of all light chains and can be recognised serologically as well as by their specific amino acid sequence.
(12 Dec 1998)
immunoglobulins, lambda-chain One of the light chains of the immunoglobulins with a molecular weight of approximately 22 kD. They constitute about 40% of all light chains and can be recognised serologically as well as by their specific amino acid sequence.
(12 Dec 1998)
immunoglobulins, light-chain Polypeptide chains, consisting of 211 to 217 amino acid residues, isolated from immunoglobulins and having a molecular weight of approximately 22 kD. There are two major types of light chains, kappa and lambda. In man they are found in a ratio of 60% to 40%, respectively. Both chains consist of linear repeating, similar, but not identical, segments of about 110 amino acid residues. In each segment a disulfide bond establishes a tightly folded approximately 60-membered loop or domain. Adjacent domains are linked by less tightly folded regions. Both light chains contain two such domains. Two light and two heavy chains make one immunoglobulin molecule, but both light chains in one ig are of the same type.
(12 Dec 1998)
immunoglobulins, mu-chain Heavy chains found in the fab and fc fragments of IgM and having a molecular weight of approximately 72 kD. They contain about 57 amino acid residues arranged in five domains and have more oligosaccharide branches and a higher carbohydrate content than the heavy chains of IgG.
(12 Dec 1998)
immunoglobulins, thyroid-stimulating Autoantibodies that bind to the thyroid-stimulating hormone (tsh) receptor (receptors, thyrotropin) on thyroid epithelial cells. The autoantibodies mimic tsh causing an unregulated production of thyroid hormones characteristic of graves' disease.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • air-to-surface
    °ø´ëÁöÀÇ
  • surface
    Ç¥¸é,Ç¥¸éÀÇ
  • imposing stone(table,surface)
    (ÀÎ)Á¤ÆÇ´ë
  • surface
    Ç¥¸éÀ» ºÙÀÌ´Ù;ÆÇÆÇÇÏ°Ô ÇÏ´Ù;Æ÷ÀåÇÏ´Ù
  • surface
    na;Ç¥¸é(ÀÇ);¿Ü°ü(ÀÇ);°Ñº¸±â(»ÓÀÇ);¸é
  • surface car
    ³ë¸é ÀüÂ÷
  • surface mail
    (Ç×°ø ¿ìÆí¿¡ ´ëÇÏ¿©)Áö»ó ÇØ»ó ¼ö¼Û ¿ìÆí
  • surface noise
    (·¹ÄÚµåÀÇ)¹Ù´Ã ¼Ò¸® (ÀâÀ½)
  • surface printing
    ºí·ÏÆÇ Àμâ(³¯¿°)
  • surface tension
    Ç¥¸é Àå·Â
  • surface water
    ÁöÇ¥¼ö(ÁöÇϼö¿¡ ´ëÇØ);Ç¥¸é ¼ö·®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á